DTaP-IPV-Hib

BIOLOGICAL2 trials

Sponsors

CanSino Biologics Inc., Sinovac Biotech Co., Ltd

Conditions

Diphtheria, Tetanus and Acellular PertussisPoliomyelitis

Phase 3

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)

Active, not recruitingNCT05951725

CanSino Biologics Inc.Diphtheria, Tetanus and Acellular Pertussis

Start: 2023-08-11End: 2025-04-01Updated: 2025-03-17

Phase 4

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

RecruitingNCT07354269

Sinovac Biotech Co., LtdPoliomyelitis

Start: 2025-09-26End: 2026-05-02Target: 180Updated: 2026-01-21